Trial Profile
Evaluation of the Efficacy of Exparel Delivered Into the Hip Capsule During Hemiarthroplasty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2023
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms HEAT
- 31 Oct 2023 Status changed from recruiting to completed.
- 09 Aug 2022 Planned End Date changed from 30 Jul 2019 to 31 Dec 2023.
- 09 Aug 2022 Planned primary completion date changed from 1 Jul 2019 to 31 Dec 2023.